Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system. The com...
Q1 2026
May 6, 2026
FY 2025
Mar 19, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 12, 2025